CD3+CD4− T cells also comprise additional T cell subsets at low levels within the TME, most notably γδ T cells which are typically associated with favorable outcomes due to their roles in anti-tumor immunity alongside CD8+ TILs [40]. This evidence concerns the gene CD4 and neoplasm.